NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers
PHASE3
This is a multi-centre, long term, double blind, clinical protocol for Nana...
A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
PHASE3
HS-10241, an oral and highly selective MET-TKI, may contribute to overcomin...
An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy
PHASE3
In this study, all patients must have already completed first-line chemothe...
Evaluation of Efficacy and Toxicity of Nivolumab Monotherapy for Advanced Non-small Cell Lung Cancer After First-line Treatment Failure Based on Second-generation Sequencing and Liquid Chip Platform
N/A
In order to understand the efficacy and side effects of lung cancer immunot...
Status
Unknown
Location
Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital of Guangzhou Medical University
Start Date
2018-05-01
Trial ID
NCT03692442
A Study to Learn About the Awareness and Knowledge That Doctors Have About the Safety and Safe Use Information for Androcur and Other Cyproterone Acetate Treatments in Europe
N/A
Androcur is a type of treatment called cyproterone acetate (CPA). Androcur ...